DEA Grants Import Permit for Psilocybin Truffles to Red Light Holland and Irvine Labs

LOS ANGELES- Red Light Holland Corp, an Ontario-based producer of psilocybin truffles, announced that its U.S. partner, Irvine Labs, has received a Controlled Substances Import Permit from the Drug Enforcement Administration (DEA). This authorization allows the importation of 3 kilograms of raw psilocybin truffles from the company’s facility in Horst, Netherlands, to Irvine Labs’ FDA-compliant and DEA-registered facility in California.

The imported truffles will be utilized in the development of extended shelf-life microdosing capsules. These capsules are intended for emerging markets and potential inclusion in government-funded pilot programs and clinical trials within the United States. The collaboration aims to establish standardized products derived from naturally occurring psilocybin.

Irvine Labs, established in 1997, holds licenses for prescription and over-the-counter drug manufacturing from the California Department of Public Health. The facility is authorized to handle Schedule I substances, including psilocybin, under DEA regulations. The partnership focuses on developing precise dehydration, manufacturing, and storage protocols to maintain the integrity of natural compounds while extending product shelf life.

This development follows the DEA’s announcement of the 2025 psilocybin quotas in April, which set the framework for legal research and development activities involving psilocybin in the United States.

The importation and subsequent research signify a step forward in the exploration of psilocybin’s potential applications, particularly in the context of microdosing. However, the efficacy and safety of such applications remain subjects of ongoing scientific investigation.